Axogen Inc vs HSBC Holdings plc — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while HSBC Holdings plc trades at $99.88 (market cap $337.30B). The key difference: HSBC Holdings plc is far larger — about 163.7× Axogen Inc's market cap, and HSBC Holdings plc pays a 3.78% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | HSBC | |
|---|---|---|
Market Cap | $2.06B | $337.30B |
Sector | Technology | Technology |
52-Week High | $46.19 | $99.25 |
52-Week Low | $11.28 | $61.30 |
Enterprise Value | $1.98B | — |
Dividend Yield | — | 3.78% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
HSBC trades at $98.09, down 1.01% today but near its 52-week high of $99.47. Technical indicators show a bullish trend with strong moving average support. The bank reported $71.02B revenue and $22.29B net income for 2025, maintaining a robust 30.81% net margin. Recent news highlights strategic moves including AI partnerships with Google Cloud and potential divestitures of non-core units like its Turkey business.
HSBC presents a balanced investment case with steady profitability and strategic refocusing, but faces risks from global economic sensitivity and regulatory challenges. Analyst consensus is mixed with 38% buy ratings, suggesting cautious optimism amid execution risks.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →